5-HYDROXYINDOLACETIC ACID INCREASED

This adverse event was reported 65 times

5-HYDROXYINDOLACETIC ACID INCREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 QUINAPRIL HYDROCHLORIDE 20 0.0025
1 OCTREOTIDE ACETATE 44 0.0014
2 LINAGLIPTIN 20 0.0011
3 TELOTRISTAT ETHYL 5 0.0009
4 GLYBURIDE 20 0.0008
5 PAMIDRONATE DISODIUM 2 0.0006
6 LOPERAMIDE HYDROCHLORIDE 22 0.0005
7 EVEROLIMUS TABLETS 7 0.0004
8 LANREOTIDE ACETATE 3 0.0004
9 LUTETIUM LU 177 DOTATATE 2 0.0003
See all drugs enriched for association with 5-HYDROXYINDOLACETIC ACID INCREASED

5-HYDROXYINDOLACETIC ACID INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dipeptidyl Peptidase 4 Inhibitor [EPC] 20 0.0006
1 Sulfonylurea [EPC] 20 0.0002
2 Somatostatin Analog [EPC] 1 0.0001
3 Thiazide Diuretic [EPC] 22 0.0001
4 Topoisomerase Inhibitor [EPC] 5 0.0001
5 Prostaglandin E1 Analog [EPC] 1 0.0001
6 Vitamin D3 Analog [EPC] 1 0.0000
7 HMG-CoA Reductase Inhibitor [EPC] 16 0.0000
8 Aluminum Complex [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 10 0.0000
See all drug classes enriched for association with 5-HYDROXYINDOLACETIC ACID INCREASED